期刊文献+

提高重组毕赤酵母表达hIFNβ-HSA的碳源控制策略 被引量:2

A Carbon-controlling Strategy to Enhancement of the Expression for Human IFNβ-HSA Fusion Protein with Pichia pastoris
下载PDF
导出
摘要 研究了重组毕赤酵母KM71/IH菌体生长阶段饥饿培养对其细胞相对活性及人β干扰素-血清白蛋白融合蛋白(hIFNβ-HSA)表达的影响.结果表明,在以甘油为唯一碳源的细胞培养后期进行饥饿培养以耗尽培养基中的甘油会导致重组细胞相对活性的降低,进而减少hIFNβ-HSA的表达量.在此基础上,提出了菌体培养后期,即过渡阶段流加甘露醇碳源代替饥饿培养的策略,不仅可以消除培养液中甘油残留对甲醇诱导表达hIFNβ-HSA的不利影响,而且能够保持重组细胞培养物较高的相对活性(>97%),从而可以提高甲醇诱导表达hIFNβ-HSA的水平,表达量可达37.3mg/L,最大生产强度为0.78mg/(L-h),较对照分别提高了92.3%和44.4% The relationship between the starvation culture and relative cell viability in the growth phase and their effects on the expression of recombinant human IFNβ-HSA fusion protein in Pichia pastoris KM71/IH were observed in 5 L fermentor experiments. The results showed that the starvation culture in which glycerol as the solo carbon source was exhausted resulted in the decrease of relative cell viability and expression of recombinant hIFNβ-HSA fusion protein. The strategy of mannitol addition in the transition stage not only eliminated the inhibition effect on methanol induction by residual glycerol, but also kept higher relative cell viability (〉97%) and then improved the yield of human IFNβ-HSA fusion protein. The maximum yield and maximum hIFNβ-HSA productivity reached 37.3 mg/L and 0.78 mg/(L-h) respectively, which were 92.3% and 44.4% higher than those in the control.
出处 《过程工程学报》 CAS CSCD 北大核心 2007年第6期1181-1186,共6页 The Chinese Journal of Process Engineering
基金 国家高技术研究发展计划(863)基金资助项目(编号:2006AA02Z153) 国家重点基础研究发展规划(973)基金资助项目(编号:2007CB707804) 上海市科学技术委员会生物医药重大科技攻关基金资助项目(编号:06DZ19020)
关键词 巴斯德毕赤酵母 细胞相对活性 非抑制表达碳源 人β干扰素-血清白融合蛋白 Pichiapastoris relative cell viability non-repressing carbon source human IFNβ-HSA fusion protein
  • 相关文献

参考文献17

  • 1张振龙,刘建源,杨云凯,邓宛明,崔春青,王淑芳,汤燕文,赵建英.重组人干扰素βSer^(17)的制备及其对SARS病毒的抑制作用[J].中国生物制品学杂志,2005,18(6):501-503. 被引量:4
  • 2唱韶红,巩新,杨志愉,王同映,马国昌,马清钧,吴军.人血清白蛋白和人干扰素α2b的融合蛋白在毕赤酵母中的表达[J].生物工程学报,2006,22(2):173-179. 被引量:16
  • 3雷楗勇,张莲芬,杨健良,金坚.人β干扰素-血清白蛋白融合蛋白在毕赤酵母中的分泌表达[J].中国生物工程杂志,2006,26(7):13-18. 被引量:20
  • 4Curvers S, Brixius P, Klauser T, et al. Human Chymotrypsinogen B Production with Pichia pastoris by Integrated Development of Fermentation and Downstream Processing [J]. Biotechnol. Progr., 2001, 17: 495-502.
  • 5谢静莉,周庆玮,张励,叶勤,辛利,杜鹏,甘人宝.表达血管生长抑制素的重组毕赤酵母在诱导阶段混合碳源的流加[J].生物工程学报,2003,19(4):467-470. 被引量:6
  • 6Whittaker M M, Whittaker J W. Expression of Recombinant Galactose Oxidase by Pichia pastoris [J]. Protein Expr. Purif., 2000, 20:105-111.
  • 7Jayanta S, Bradley A P, Mehmet I, et al. Causes of Proteolytic Degradation of Secreted Recombinant Proteins Produced in Methylotrophic Yeast Pichia pastoris: Case Study with Recombinant Ovine Interferon-T [J]. Biotechnol. Bioeng., 2005, 89(1): 103-112.
  • 8Li Z J, Xiong F, Lin Q S, et al. Low-temperature Increases the Yield of Biologically Active Herring Antifreeze Protein in Pichia pastoris [J]. Protein Expr. Purif., 2001,21: 438-455.
  • 9Wang J, Vu N, Jacqueline G, et al. Improved Yield of Recombinant Merozoite Surface Protein 3 (MSP3) from Pichia pastoris Using Chemically Defined Media [J]. Biotechnol. Bioeng., 2005, 90(7): 838-847.
  • 10Haitao R, Yuan J Q. Model-based Specific Growth Rate Control for Pichia pastoris to Improve Recombinant Protein Production [J]. J. Chem. Technol. Biotechnol., 2005, 80: 1268-1272.

二级参考文献44

  • 1罗东.干扰素剂型研究进展[J].中国新医药,2003,2(9):49-51. 被引量:6
  • 2赵洪亮,薛冲,熊向华,张伟,杨秉芬,刘志敏.人血清白蛋白-睫状神经营养因子突变体融合蛋白基因在毕赤酵母中的表达及表达产物的纯化和活性鉴定[J].生物工程学报,2005,21(2):254-258. 被引量:7
  • 3Utsumi J,Shimizu H.Human interferon β,protein structure and function.In:Baron S,Coppernhaver D H.eds.Interferon:Principles and Medical Applications.Galveston:The University of Texas Medical Branch at Galveston,1992.107 ~116
  • 4颜了颖,王海林.精编分子生物学实验指南.北京:科学出版社,1998.523
  • 5Peters T Jr.Serum albumin.Adv Protein Chem,1985,37:161~245
  • 6Chang T W,Yu L.Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide.US patent,5723125 A.1998-3-3
  • 7Markaryan A,Morozova I,Lee B S,et al.A typical processing of amyloid precursor fusion protein by proteolytic activity in Pichia pastoris.Biochem Biophys Res Commun,1999,262:263~ 268
  • 8Kang H A,Choi E S,Hong W K,et al.Proteolytic stability of recombinant human serum albumin secreted in the yeast Saccharomyces cerevisiae.Appl Microbiol Biotechnol,2000,53:575 ~ 582
  • 9Cinatl J,Morgenstem B,Chandra P,et al. Treatent of SARS with human interferons. TheLancet,2003,362:293-294.
  • 10Mark DF,Lu SD,Crease AA, et al. Site-specific mutagenesis of human fibroblastinterferon gene. Proc Natl Acad Sci USA, 1984,81:5662-5666.

共引文献51

同被引文献93

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部